GSK-2838232
CAS No. 1443460-91-0
GSK-2838232( GSK2838232 )
Catalog No. M11882 CAS No. 1443460-91-0
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 125 | Get Quote |
|
10MG | 200 | Get Quote |
|
25MG | 439 | Get Quote |
|
50MG | 641 | Get Quote |
|
100MG | 888 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-2838232
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
-
DescriptionGSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.HIV Infection Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK2838232
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number1443460-91-0
-
Formula Weight809.57
-
Molecular FormulaC48H73ClN2O6
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL 61.76 mM
-
SMILESO=C(O)C(C)(C)CC(O[C@@H](CC[C@]1(C)[C@@]2([H])CC[C@@]34[H])C(C)(C)[C@]1([H])CC[C@@]2(C)[C@]3(C)CC[C@]5([C@@H](O)CN(CC6=CC=CC(Cl)=C6)CCN(C)C)C4=C(C(C)C)C(C5)=O)=O
-
Chemical Name(3b)-3-(3-Carboxy-3-methyl-1-oxobutoxy)-17-[(1R)-2-[[(4-chlorophenyl)methyl][2-(dimethylamino)ethyl]amino]-1-hydroxyethyl]-28-norlup-18-en-21-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DRB
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).
-
BMS-818251
BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.
-
IC-9564
IC-9564 (AIDS033640) is a betulinic acid derivative and potent HIV entry inhibitor.